NDC Package 70436-028-80 Sodium Nitroprusside

Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70436-028-80
Package Description:
1 VIAL in 1 CARTON / 2 mL in 1 VIAL
Product Code:
Proprietary Name:
Sodium Nitroprusside
Non-Proprietary Name:
Sodium Nitroprusside
Substance Name:
Sodium Nitroprusside
Usage Information:
Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized.Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery.Sodium nitroprusside is also indicated for the treatment of acute congestive heart failure.
11-Digit NDC Billing Format:
70436002880
NDC to RxNorm Crosswalk:
  • RxCUI: 240793 - sodium nitroprusside 50 MG in 2 ML Injection
  • RxCUI: 240793 - 2 ML sodium nitroprusside 25 MG/ML Injection
  • RxCUI: 240793 - sodium nitroprusside 25 MG/ML per 2 ML Injection
  • RxCUI: 240793 - sodium nitroprusside 50 MG per 2 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Slate Run Pharmaceuticals, Llc
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA214199
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-15-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70436-028-80?

    The NDC Packaged Code 70436-028-80 is assigned to a package of 1 vial in 1 carton / 2 ml in 1 vial of Sodium Nitroprusside, a human prescription drug labeled by Slate Run Pharmaceuticals, Llc. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 70436-028 included in the NDC Directory?

    Yes, Sodium Nitroprusside with product code 70436-028 is active and included in the NDC Directory. The product was first marketed by Slate Run Pharmaceuticals, Llc on October 15, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70436-028-80?

    The 11-digit format is 70436002880. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270436-028-805-4-270436-0028-80